Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06199570 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Support for Cancer Patients Awaiting News

Study acronym: SCAN
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 6 months later Dec 30, 2026 → Jul 1, 2027
See other at-risk trials from Hackensack Meridian Health

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Dec 30, 2026 to Jul 1, 2027
    • Eligibility criteria expanded, about 10 words
    v11
  2. Re-verified, no change to tracked fieldsv10
  3. Primary and study completion dates: Apr 30, 2025 to Dec 30, 2026v9 Show 5 more changesShow less
    • Primary endpoints: 5 to 10
    • Eligibility criteria expanded, about 7 words
    • Secondary endpoints: 3 to 8
    • Site contact updated
    • Study description shortened, about 1 word
  4. Site contact updated
    • Eligibility criteria expanded, about 2 words
    v8
  5. Eligibility criteria revisedv7
Show 5 earlier versionsHide 5 earlier versions
  1. Primary and study completion dates: Jan 30, 2025 to Apr 30, 2025
    • Start date changed from estimate of Apr 15, 2024 to May 1, 2024
    v6
  2. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v5
  3. Eligibility criteria expanded, about 1 wordv4
  4. Start date: Feb 25, 2024 to Apr 15, 2024v3
  5. Start date: Jan 10, 2024 to Feb 25, 2024
    • Primary and study completion dates: Nov 30, 2024 to Jan 30, 2025
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a behavioral trial study to pilot test a stress management intervention for people with cancer who are undergoing routine cancer scans. The study will involve two pilot testing phases. Initial feasibility will be determined in an Open Trial phase, to inform any needed revisions to the intervention and/or protocol prior to a Pilot Randomized Controlled Trial phase. The Open Trial phase is an unblinded, single-site, single-arm open trial (n=10). The Pilot randomized clinical trial (RCT) phase is an unblinded, single-site, feasibility pilot randomized controlled trial (n=50).
Trial Details
NCT Number NCT06199570
Lead Sponsor Hackensack Meridian Health
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)		 Lung Cancer
Related terms Lung Neoplasms
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov